Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diacerein reduces inflammasome activation and SARS-CoV-2 virus replication: a proof-of-concept translational study.
Carmo HRP, Castillo AR, Bonilha I, Gomes EIL, Barreto J, Moura FA, Davanzo GG, de Brito Monteiro L, Muraro SP, Fabiano de Souza G, Morari J, Galdino FE, Brunetti NS, Reis-de-Oliveira G, Carregari VC, Nadruz W, Martins-de-Souza D, Farias AS, Velloso LA, Proenca-Modena JL, Mori MA, Loh W, Bhatt DL, Yellon DM, Davidson SM, De Oliveira PG, Moraes-Vieira PM, Sposito AC. Carmo HRP, et al. Among authors: bonilha i. Front Pharmacol. 2024 Oct 7;15:1402032. doi: 10.3389/fphar.2024.1402032. eCollection 2024. Front Pharmacol. 2024. PMID: 39434905 Free PMC article.
Dapagliflozin cardiovascular effects on end-stage kidney disease (DARE-ESKD-2) trial: rationale and design.
Barreto J, Martins M, Pascoa M, Medorima STK, Bonilha I, Jesus DC, Carbonara CEM, Quadros KRS, Assato B, Campos-Staffico AM, Júnior GG, Nadruz W, de Oliveira RB, Sposito AC. Barreto J, et al. Among authors: bonilha i. Expert Opin Drug Saf. 2024 Oct 13:1-7. doi: 10.1080/14740338.2024.2412228. Online ahead of print. Expert Opin Drug Saf. 2024. PMID: 39377184
Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial.
Bonilha I, Gomes ÉIL, Carmo HRP, Breder I, Barreto J, Breder J, Munhoz DB, Carvalho LSF, Quinaglia T, Kimura-Medorima ST, Gossi CM, Zimetti F, Nadruz W, Zanotti I, Sposito AC; EXCEED-BHS3 Group. Bonilha I, et al. Int J Mol Sci. 2024 Apr 8;25(7):4108. doi: 10.3390/ijms25074108. Int J Mol Sci. 2024. PMID: 38612917 Free PMC article.
Dapagliflozin cardiovascular effects on end-stage kidney disease (DARE-ESKD-2) trial: rationale and design.
Barreto J, Martins M, Pascoa M, Medorima STK, Bonilha I, Jesus DC, Carbonara CEM, Quadros KRS, Assato B, Campos-Staffico AM, Júnior GG, Nadruz W, de Oliveira RB, Sposito AC. Barreto J, et al. Among authors: bonilha i. Res Sq [Preprint]. 2023 Oct 19:rs.3.rs-3434207. doi: 10.21203/rs.3.rs-3434207/v1. Res Sq. 2023. Update in: Expert Opin Drug Saf. 2024 Oct 13:1-7. doi: 10.1080/14740338.2024.2412228 PMID: 37886458 Free PMC article. Updated. Preprint.
Comparative effectiveness and cost-effectiveness of cardioprotective glucose-lowering therapies for type 2 diabetes in Brazil: a Bayesian network model.
Nogueira ACC, Barreto J, Moura FA, Luchiari B, Abuhab A, Bonilha I, Nadruz W, Gaziano JM, Gaziano T, de Carvalho LSF, Sposito AC; Brazilian Heart Study Group. Nogueira ACC, et al. Among authors: bonilha i. Health Econ Rev. 2023 Oct 25;13(1):50. doi: 10.1186/s13561-023-00466-3. Health Econ Rev. 2023. PMID: 37878108 Free PMC article.
Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19.
Carmo HRP, Yoshinaga MY, Castillo AR, Britto Chaves-Filho A, Bonilha I, Barreto J, Muraro SP, de Souza GF, Davanzo GG, Perroud MW Jr, Lukhna K, Ntsekhe M, Davidson S, Velloso LA, Nadruz W, Carvalho LSF, Sáinz-Jaspeado M, Farias AS, Proença-Módena JL, Moraes-Vieira PM, Karathanasis SK, Yellon D, Miyamoto S, Remaley AT, Sposito AC. Carmo HRP, et al. Among authors: bonilha i. Mol Genet Metab. 2023 Apr;138(4):107552. doi: 10.1016/j.ymgme.2023.107552. Epub 2023 Feb 27. Mol Genet Metab. 2023. PMID: 36889041 Free PMC article.
Very low HDL levels: clinical assessment and management.
Bonilha I, Luchiari B, Nadruz W, Sposito AC. Bonilha I, et al. Arch Endocrinol Metab. 2023 Jan 18;67(1):3-18. doi: 10.20945/2359-3997000000585. Arch Endocrinol Metab. 2023. PMID: 36651718 Free PMC article. Review.
Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trial.
Sposito AC, Breder I, Barreto J, Breder J, Bonilha I, Lima M, Oliveira A, Wolf V, Luchiari B, do Carmo HR, Munhoz D, Oliveira D, Coelho-Filho OR, Coelho OR, Matos-Souza JR, Moura FA, de Carvalho LSF, Nadruz W, Quinaglia T, Kimura-Medorima ST; EXCEED-BHS3 Group. Sposito AC, et al. Among authors: bonilha i. Cardiovasc Diabetol. 2022 Aug 6;21(1):147. doi: 10.1186/s12933-022-01584-8. Cardiovasc Diabetol. 2022. PMID: 35933413 Free PMC article. Clinical Trial.
25 results